Multiple exposures to SARS-CoV-2 Spike enhance cross-reactive antibody-dependent cellular cytotoxicity against SARS-CoV-1
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (177958)
- Canadian Institutes of Health Research (RN497587-494246)
- Canada Foundation for Innovation (41027)
- Mitacs (FBD-193357)
- Santé
- Fondation du CHUM
This publication has 54 references indexed in Scilit:
- Virological characteristics of the SARS-CoV-2 Omicron BA.2 spikeCell, 2022
- Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concernCell Reports, 2022
- Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjectsCell Reports, 2021
- Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protectionCell, 2021
- Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 MortalityCell, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Hosts and Sources of Endemic Human Coronaviruses2018
- Viral Etiology of Severe Pneumonia Among Kenyan Infants and ChildrenJAMA, 2010
- Immunogenicity of the spike glycoprotein of Bat SARS-like coronavirusVirologica Sinica, 2010
- Isolation of rhinoviruses and coronaviruses from 38 colds in adultsJournal of Medical Virology, 1980